nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxycycline—MMP8—atherosclerosis	0.342	0.591	CbGaD
Doxycycline—MMP1—atherosclerosis	0.237	0.409	CbGaD
Doxycycline—SLC22A11—Pravastatin—atherosclerosis	0.102	0.392	CbGbCtD
Doxycycline—SLC22A8—Pravastatin—atherosclerosis	0.0591	0.228	CbGbCtD
Doxycycline—SLC22A6—Pravastatin—atherosclerosis	0.0412	0.159	CbGbCtD
Doxycycline—CYP3A4—Ezetimibe—atherosclerosis	0.0121	0.0466	CbGbCtD
Doxycycline—CYP3A4—Rosuvastatin—atherosclerosis	0.0121	0.0466	CbGbCtD
Doxycycline—CYP3A4—Simvastatin—atherosclerosis	0.0112	0.0433	CbGbCtD
Doxycycline—CYP3A4—Lovastatin—atherosclerosis	0.011	0.0424	CbGbCtD
Doxycycline—CYP3A4—Pravastatin—atherosclerosis	0.011	0.0424	CbGbCtD
Doxycycline—MMP13—leg—atherosclerosis	0.00898	0.137	CbGeAlD
Doxycycline—MMP13—hindlimb—atherosclerosis	0.00802	0.123	CbGeAlD
Doxycycline—MMP13—appendage—atherosclerosis	0.00688	0.105	CbGeAlD
Doxycycline—MMP1—leg—atherosclerosis	0.00631	0.0965	CbGeAlD
Doxycycline—MMP1—hindlimb—atherosclerosis	0.00564	0.0862	CbGeAlD
Doxycycline—MMP1—appendage—atherosclerosis	0.00484	0.074	CbGeAlD
Doxycycline—MMP1—artery—atherosclerosis	0.00346	0.0528	CbGeAlD
Doxycycline—MMP1—endothelium—atherosclerosis	0.00292	0.0446	CbGeAlD
Doxycycline—MMP1—blood vessel—atherosclerosis	0.00269	0.0412	CbGeAlD
Doxycycline—MMP13—connective tissue—atherosclerosis	0.00196	0.03	CbGeAlD
Doxycycline—MMP8—connective tissue—atherosclerosis	0.00177	0.0271	CbGeAlD
Doxycycline—MMP13—cardiovascular system—atherosclerosis	0.00171	0.0261	CbGeAlD
Doxycycline—MMP7—connective tissue—atherosclerosis	0.00156	0.0239	CbGeAlD
Doxycycline—MMP8—cardiovascular system—atherosclerosis	0.00154	0.0236	CbGeAlD
Doxycycline—MMP1—connective tissue—atherosclerosis	0.00138	0.0211	CbGeAlD
Doxycycline—MMP7—cardiovascular system—atherosclerosis	0.00136	0.0208	CbGeAlD
Doxycycline—MMP8—adipose tissue—atherosclerosis	0.00136	0.0208	CbGeAlD
Doxycycline—MMP1—cardiovascular system—atherosclerosis	0.0012	0.0184	CbGeAlD
Doxycycline—MMP7—adipose tissue—atherosclerosis	0.0012	0.0184	CbGeAlD
Doxycycline—Minocycline—IL1B—atherosclerosis	0.000655	0.243	CrCbGaD
Doxycycline—Minocycline—ALOX5—atherosclerosis	0.000598	0.221	CrCbGaD
Doxycycline—Minocycline—VEGFA—atherosclerosis	0.000479	0.177	CrCbGaD
Doxycycline—SLC22A11—liver—atherosclerosis	0.000471	0.0072	CbGeAlD
Doxycycline—Minocycline—MMP9—atherosclerosis	0.000463	0.171	CrCbGaD
Doxycycline—Methacycline—ALB—atherosclerosis	0.000352	0.13	CrCbGaD
Doxycycline—Tetracycline—ALB—atherosclerosis	0.000154	0.0571	CrCbGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—STAT3—atherosclerosis	0.000145	0.00154	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—STAT3—atherosclerosis	0.000144	0.00153	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IFNG—atherosclerosis	0.000142	0.0015	CbGpPWpGaD
Doxycycline—MMP1—Cell surface interactions at the vascular wall—F2—atherosclerosis	0.000142	0.0015	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—MAPK3—atherosclerosis	0.000139	0.00148	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—STAT3—atherosclerosis	0.000139	0.00147	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—SPP1—atherosclerosis	0.000137	0.00146	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—MAPK3—atherosclerosis	0.000137	0.00146	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—TGFB1—atherosclerosis	0.000137	0.00145	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—SIRT1—atherosclerosis	0.000136	0.00144	CbGpPWpGaD
Doxycycline—MMP13—Collagen formation—MMP9—atherosclerosis	0.000133	0.00141	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—MAPK3—atherosclerosis	0.000133	0.00141	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SERPINC1—atherosclerosis	0.000132	0.0014	CbGpPWpGaD
Doxycycline—CYP3A4—liver—atherosclerosis	0.000132	0.00201	CbGeAlD
Doxycycline—MMP1—AP-1 transcription factor network—CXCL8—atherosclerosis	0.000132	0.0014	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP2—atherosclerosis	0.000131	0.00139	CbGpPWpGaD
Doxycycline—MMP7—Collagen formation—MMP9—atherosclerosis	0.000129	0.00137	CbGpPWpGaD
Doxycycline—MMP13—Degradation of the extracellular matrix—MMP9—atherosclerosis	0.000127	0.00135	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—PDGFB—atherosclerosis	0.000127	0.00135	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—MAPK8—atherosclerosis	0.000126	0.00134	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP1—atherosclerosis	0.000126	0.00133	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—PLG—atherosclerosis	0.000125	0.00133	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—NFKB1—atherosclerosis	0.000125	0.00133	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IFNG—atherosclerosis	0.000125	0.00132	CbGpPWpGaD
Doxycycline—MMP1—Validated transcriptional targets of AP1 family members Fra1 and Fra2—IL6—atherosclerosis	0.000123	0.00131	CbGpPWpGaD
Doxycycline—MMP7—Degradation of the extracellular matrix—MMP9—atherosclerosis	0.000123	0.0013	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—MAPK8—atherosclerosis	0.000123	0.0013	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—VCAM1—atherosclerosis	0.000122	0.0013	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—PLG—atherosclerosis	0.000121	0.00129	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG1—atherosclerosis	0.00012	0.00127	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—MMP9—atherosclerosis	0.000119	0.00126	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—VCAM1—atherosclerosis	0.000118	0.00125	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—CAV1—atherosclerosis	0.000118	0.00125	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—CXCL8—atherosclerosis	0.000116	0.00123	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP3—atherosclerosis	0.000115	0.00122	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—ICAM1—atherosclerosis	0.000114	0.00121	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—VEGFA—atherosclerosis	0.000113	0.0012	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—STAT3—atherosclerosis	0.000112	0.00119	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP3—atherosclerosis	0.000111	0.00118	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—F3—atherosclerosis	0.000111	0.00118	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—MAPK3—atherosclerosis	0.00011	0.00117	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP7A1—atherosclerosis	0.000109	0.00115	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—MAPK3—atherosclerosis	0.000107	0.00114	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—F5—atherosclerosis	0.000105	0.00111	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SELP—atherosclerosis	0.000105	0.00111	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—NFKB1—atherosclerosis	0.000104	0.0011	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—ESR1—atherosclerosis	0.000102	0.00109	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—MAPK8—atherosclerosis	0.000102	0.00108	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—SPP1—atherosclerosis	0.0001	0.00106	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CLU—atherosclerosis	0.0001	0.00106	CbGpPWpGaD
Doxycycline—MMP1—Integrated Cancer Pathway—AKT1—atherosclerosis	9.89e-05	0.00105	CbGpPWpGaD
Doxycycline—MMP1—Degradation of the extracellular matrix—MMP9—atherosclerosis	9.82e-05	0.00104	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—TGFB1—atherosclerosis	9.81e-05	0.00104	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP2—atherosclerosis	9.72e-05	0.00103	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—PLG—atherosclerosis	9.68e-05	0.00103	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—SPP1—atherosclerosis	9.68e-05	0.00103	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—SERPINE1—atherosclerosis	9.54e-05	0.00101	CbGpPWpGaD
Doxycycline—MMP13—Endochondral Ossification—AKT1—atherosclerosis	9.49e-05	0.00101	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—VCAM1—atherosclerosis	9.45e-05	0.001	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—THBD—atherosclerosis	9.42e-05	0.001	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCG5—atherosclerosis	9.41e-05	0.000999	CbGpPWpGaD
Doxycycline—MMP13—Oncostatin M Signaling Pathway—AKT1—atherosclerosis	9.37e-05	0.000995	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—PDGFB—atherosclerosis	9.27e-05	0.000984	CbGpPWpGaD
Doxycycline—MMP13—AGE/RAGE pathway—AKT1—atherosclerosis	9.26e-05	0.000983	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP1—atherosclerosis	9.17e-05	0.000973	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—PLA2G7—atherosclerosis	9.12e-05	0.000968	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—PDGFB—atherosclerosis	8.96e-05	0.000951	CbGpPWpGaD
Doxycycline—MMP7—AGE/RAGE pathway—AKT1—atherosclerosis	8.94e-05	0.000949	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SELE—atherosclerosis	8.93e-05	0.000948	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—MAPK3—atherosclerosis	8.91e-05	0.000946	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP1—atherosclerosis	8.85e-05	0.00094	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP3—atherosclerosis	8.85e-05	0.00094	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ABCG4—atherosclerosis	8.84e-05	0.000938	CbGpPWpGaD
Doxycycline—MMP7—p75(NTR)-mediated signaling—AKT1—atherosclerosis	8.63e-05	0.000916	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ABCG8—atherosclerosis	8.48e-05	0.0009	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—ICAM1—atherosclerosis	8.33e-05	0.000884	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—ICAM1—atherosclerosis	8.05e-05	0.000854	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VWF—atherosclerosis	7.96e-05	0.000845	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—SPP1—atherosclerosis	7.74e-05	0.000821	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—F7—atherosclerosis	7.59e-05	0.000806	CbGpPWpGaD
Doxycycline—CYP3A4—Estrogen metabolism—GSTM1—atherosclerosis	7.46e-05	0.000792	CbGpPWpGaD
Doxycycline—MMP1—Endothelins—AKT1—atherosclerosis	7.42e-05	0.000788	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—HSPD1—atherosclerosis	7.41e-05	0.000786	CbGpPWpGaD
Doxycycline—MMP1—AP-1 transcription factor network—IL6—atherosclerosis	7.39e-05	0.000785	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—MMP9—atherosclerosis	7.31e-05	0.000776	CbGpPWpGaD
Doxycycline—MMP1—Oncostatin M Signaling Pathway—AKT1—atherosclerosis	7.24e-05	0.000768	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—PDGFB—atherosclerosis	7.16e-05	0.00076	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP2—atherosclerosis	7.09e-05	0.000753	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—MAPK8—atherosclerosis	6.97e-05	0.00074	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—SERPINE1—atherosclerosis	6.96e-05	0.000739	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP7A1—atherosclerosis	6.9e-05	0.000732	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP2—atherosclerosis	6.85e-05	0.000727	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP7A1—atherosclerosis	6.81e-05	0.000723	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLAT—atherosclerosis	6.76e-05	0.000718	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ABCG4—atherosclerosis	6.74e-05	0.000716	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—SERPINE1—atherosclerosis	6.72e-05	0.000714	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ABCG1—atherosclerosis	6.7e-05	0.000711	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—IL6—atherosclerosis	6.51e-05	0.000692	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ABCG8—atherosclerosis	6.46e-05	0.000686	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—ICAM1—atherosclerosis	6.43e-05	0.000683	CbGpPWpGaD
Doxycycline—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27A1—atherosclerosis	6.38e-05	0.000677	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—NFKB1—atherosclerosis	6.37e-05	0.000676	CbGpPWpGaD
Doxycycline—CYP3A4—Oxidation by Cytochrome P450—CYP27A1—atherosclerosis	6.29e-05	0.000668	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	6.07e-05	0.000645	CbGpPWpGaD
Doxycycline—MMP8—Extracellular matrix organization—TGFB1—atherosclerosis	6.02e-05	0.000639	CbGpPWpGaD
Doxycycline—MMP1—Glucocorticoid receptor regulatory network—AKT1—atherosclerosis	6.01e-05	0.000638	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—F7—atherosclerosis	5.97e-05	0.000634	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—KNG1—atherosclerosis	5.94e-05	0.00063	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—TGFB1—atherosclerosis	5.91e-05	0.000627	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLAUR—atherosclerosis	5.89e-05	0.000625	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—VEGFA—atherosclerosis	5.78e-05	0.000614	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PLG—atherosclerosis	5.75e-05	0.000611	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ABCG4—atherosclerosis	5.63e-05	0.000597	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—atherosclerosis	5.61e-05	0.000596	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP7A1—atherosclerosis	5.59e-05	0.000594	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SOD1—atherosclerosis	5.51e-05	0.000585	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP2—atherosclerosis	5.48e-05	0.000581	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—TRPV1—atherosclerosis	5.46e-05	0.00058	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ABCG8—atherosclerosis	5.39e-05	0.000573	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—SERPINE1—atherosclerosis	5.37e-05	0.00057	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—MMP9—atherosclerosis	5.33e-05	0.000566	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—GHRL—atherosclerosis	5.32e-05	0.000565	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ABCG5—atherosclerosis	5.26e-05	0.000558	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IGF2—atherosclerosis	5.24e-05	0.000556	CbGpPWpGaD
Doxycycline—CYP3A4—Phase 1 - Functionalization of compounds—CYP27A1—atherosclerosis	5.17e-05	0.000549	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—ACE—atherosclerosis	5.15e-05	0.000547	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—MMP9—atherosclerosis	5.15e-05	0.000547	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ABCG1—atherosclerosis	5.11e-05	0.000542	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—APOB—atherosclerosis	5.08e-05	0.00054	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PRKCG—atherosclerosis	4.72e-05	0.000501	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	4.63e-05	0.000492	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—PLAUR—atherosclerosis	4.63e-05	0.000491	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CD36—atherosclerosis	4.61e-05	0.00049	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—PLG—atherosclerosis	4.52e-05	0.00048	CbGpPWpGaD
Doxycycline—MMP13—Extracellular matrix organization—TGFB1—atherosclerosis	4.39e-05	0.000466	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ABCG1—atherosclerosis	4.26e-05	0.000453	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PDGFB—atherosclerosis	4.25e-05	0.000452	CbGpPWpGaD
Doxycycline—MMP7—Extracellular matrix organization—TGFB1—atherosclerosis	4.24e-05	0.000451	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—TRPV1—atherosclerosis	4.17e-05	0.000442	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—IGF2—atherosclerosis	4.12e-05	0.000437	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—MMP9—atherosclerosis	4.12e-05	0.000437	CbGpPWpGaD
Doxycycline—MMP1—TGF-beta Signaling Pathway—AKT1—atherosclerosis	4.11e-05	0.000436	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—CAV1—atherosclerosis	4.03e-05	0.000428	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—APOA1—atherosclerosis	4.02e-05	0.000427	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ABCG5—atherosclerosis	4.01e-05	0.000426	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—CETP—atherosclerosis	3.89e-05	0.000413	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atherosclerosis	3.89e-05	0.000413	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—CYP7A1—atherosclerosis	3.87e-05	0.00041	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—F2—atherosclerosis	3.84e-05	0.000407	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS2—atherosclerosis	3.79e-05	0.000403	CbGpPWpGaD
Doxycycline—MMP1—Integrated Breast Cancer Pathway—AKT1—atherosclerosis	3.69e-05	0.000391	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—PIK3CG—atherosclerosis	3.67e-05	0.00039	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—TRPV1—atherosclerosis	3.48e-05	0.000369	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—PLAT—atherosclerosis	3.43e-05	0.000364	CbGpPWpGaD
Doxycycline—MMP1—Extracellular matrix organization—TGFB1—atherosclerosis	3.39e-05	0.00036	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—IGF1—atherosclerosis	3.36e-05	0.000357	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ABCG5—atherosclerosis	3.35e-05	0.000355	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—AGT—atherosclerosis	3.27e-05	0.000347	CbGpPWpGaD
Doxycycline—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—atherosclerosis	3.22e-05	0.000341	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—LEP—atherosclerosis	3.2e-05	0.00034	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—SERPINE1—atherosclerosis	3.19e-05	0.000339	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—ALB—atherosclerosis	3.19e-05	0.000338	CbGpPWpGaD
Doxycycline—SLC22A11—SLC-mediated transmembrane transport—ALB—atherosclerosis	3.18e-05	0.000338	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—NOS3—atherosclerosis	3.05e-05	0.000324	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—F2—atherosclerosis	3.02e-05	0.00032	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP7A1—atherosclerosis	2.97e-05	0.000315	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—CETP—atherosclerosis	2.97e-05	0.000315	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP7A1—atherosclerosis	2.93e-05	0.000311	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—PLG—atherosclerosis	2.92e-05	0.00031	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—CYP27A1—atherosclerosis	2.75e-05	0.000292	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—INS—atherosclerosis	2.73e-05	0.00029	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—CYP27A1—atherosclerosis	2.71e-05	0.000288	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.69e-05	0.000286	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CCL2—atherosclerosis	2.69e-05	0.000286	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—IGF1—atherosclerosis	2.65e-05	0.000281	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.62e-05	0.000278	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—APOB—atherosclerosis	2.58e-05	0.000274	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—MMP2—atherosclerosis	2.56e-05	0.000272	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—CETP—atherosclerosis	2.48e-05	0.000263	CbGpPWpGaD
Doxycycline—SLC22A8—SLC-mediated transmembrane transport—ALB—atherosclerosis	2.43e-05	0.000257	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—PLG—atherosclerosis	2.22e-05	0.000236	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—VEGFA—atherosclerosis	2.2e-05	0.000233	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—PLAT—atherosclerosis	2.18e-05	0.000232	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—PPARA—atherosclerosis	2.17e-05	0.000231	CbGpPWpGaD
Doxycycline—MMP1—Metabolism of proteins—CXCL8—atherosclerosis	2.13e-05	0.000226	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—MAPK3—atherosclerosis	2.08e-05	0.000221	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—HMOX1—atherosclerosis	2.05e-05	0.000218	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—APOA1—atherosclerosis	2.04e-05	0.000217	CbGpPWpGaD
Doxycycline—SLC22A6—SLC-mediated transmembrane transport—ALB—atherosclerosis	2.02e-05	0.000215	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—TGFB1—atherosclerosis	2.02e-05	0.000214	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—APOB—atherosclerosis	1.97e-05	0.000209	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—PLG—atherosclerosis	1.86e-05	0.000197	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—HMOX1—atherosclerosis	1.71e-05	0.000182	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.66e-05	0.000176	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—APOB—atherosclerosis	1.64e-05	0.000174	CbGpPWpGaD
Doxycycline—SLC22A11—Transmembrane transport of small molecules—ALB—atherosclerosis	1.62e-05	0.000172	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.56e-05	0.000165	CbGpPWpGaD
Doxycycline—MMP1—Hemostasis—AKT1—atherosclerosis	1.4e-05	0.000149	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—PPARA—atherosclerosis	1.38e-05	0.000147	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—APOA1—atherosclerosis	1.3e-05	0.000138	CbGpPWpGaD
Doxycycline—SLC22A8—Transmembrane transport of small molecules—ALB—atherosclerosis	1.23e-05	0.000131	CbGpPWpGaD
Doxycycline—CYP3A4—Biological oxidations—GSTM1—atherosclerosis	1.23e-05	0.00013	CbGpPWpGaD
Doxycycline—CYP3A4—Metapathway biotransformation—GSTM1—atherosclerosis	1.21e-05	0.000128	CbGpPWpGaD
Doxycycline—SLC22A6—Transmembrane transport of small molecules—ALB—atherosclerosis	1.03e-05	0.000109	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LDLRAP1—atherosclerosis	8.7e-06	9.23e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PLTP—atherosclerosis	8.18e-06	8.68e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ABCG8—atherosclerosis	7.09e-06	7.53e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LTA4H—atherosclerosis	7.09e-06	7.53e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ABCG1—atherosclerosis	5.6e-06	5.95e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—FABP4—atherosclerosis	5.27e-06	5.59e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LCAT—atherosclerosis	5.27e-06	5.59e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOA4—atherosclerosis	5.17e-06	5.49e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP7A1—atherosclerosis	5.08e-06	5.39e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CYP27A1—atherosclerosis	4.7e-06	4.99e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOA2—atherosclerosis	4.45e-06	4.73e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALOX15—atherosclerosis	4.45e-06	4.73e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALOX5AP—atherosclerosis	4.45e-06	4.73e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PLA2G2A—atherosclerosis	4.45e-06	4.73e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ABCG5—atherosclerosis	4.4e-06	4.67e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LPA—atherosclerosis	4.25e-06	4.51e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—BGN—atherosclerosis	4.11e-06	4.37e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOA5—atherosclerosis	4.07e-06	4.32e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PLA2G1B—atherosclerosis	3.92e-06	4.16e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALOX5—atherosclerosis	3.79e-06	4.02e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NAMPT—atherosclerosis	3.4e-06	3.6e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LIPC—atherosclerosis	3.37e-06	3.58e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOC3—atherosclerosis	3.35e-06	3.56e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LDLR—atherosclerosis	3.33e-06	3.54e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CETP—atherosclerosis	3.26e-06	3.46e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—SCARB1—atherosclerosis	3.12e-06	3.31e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HMGCR—atherosclerosis	2.94e-06	3.13e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ABCA1—atherosclerosis	2.62e-06	2.79e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—HMOX1—atherosclerosis	2.25e-06	2.39e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOB—atherosclerosis	2.16e-06	2.29e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GSTM1—atherosclerosis	2.1e-06	2.23e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—LPL—atherosclerosis	2.06e-06	2.19e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—GPX1—atherosclerosis	2.01e-06	2.13e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CD36—atherosclerosis	1.96e-06	2.08e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—MTHFR—atherosclerosis	1.85e-06	1.97e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPARA—atherosclerosis	1.82e-06	1.93e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AGT—atherosclerosis	1.76e-06	1.87e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOE—atherosclerosis	1.73e-06	1.83e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—CAV1—atherosclerosis	1.71e-06	1.82e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—APOA1—atherosclerosis	1.71e-06	1.81e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PIK3CG—atherosclerosis	1.56e-06	1.65e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PPARG—atherosclerosis	1.5e-06	1.6e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—INS—atherosclerosis	1.47e-06	1.57e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—ALB—atherosclerosis	1.35e-06	1.44e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—NOS3—atherosclerosis	1.29e-06	1.37e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—PTGS2—atherosclerosis	1.18e-06	1.26e-05	CbGpPWpGaD
Doxycycline—CYP3A4—Metabolism—AKT1—atherosclerosis	5.94e-07	6.31e-06	CbGpPWpGaD
